Attention-deficit/hyperactivity disorder (ADHD) in the adult population is frequently
associated with comorbid psychiatric diseases that complicate its recognition, diagnosis and …

Psychostimulants, including amphetamines and methylphenidate, are first-line
pharmacotherapies for individuals with attention-deficit/hyperactivity disorder (ADHD). This …

Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common
psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD …

Attention-deficit/hyperactivity disorder (ADHD) is a common and impairing disorder affecting
children, adolescents, and adults. Several treatment strategies are available that can …

Importance In the US and the United Kingdom, cocaine use is the second leading cause of
illicit drug overdose death. Psychosocial treatments for cocaine use disorder are limited, and …

Cocaine use continues to be a serious worldwide public health problem. Cocaine abuse is
associated with substantial morbidity and mortality. Cocaine overdose deaths are increasing …

Rationale Agonist-based pharmacologic intervention is an accepted approach in treatment
of opioid and tobacco use disorders. Objectives We conducted a systematic review and …

Despite a growing literature on the complex bidirectional relationship of ADHD and
substance use, reviews specifically focusing on alcohol are scarce. ADHD and AUD show a …

Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use
disorders (SUD) and is associated with early onset and more severe development of SUD …

Background Attention deficit hyperactivity disorder (ADHD) is a childhood‐onset disorder
characterised by inattention, hyperactivity, and impulsivity. ADHD can persist into adulthood …